@article{ABS5070,
author = {John T. Cole},
title = {Estrogen receptor positive early breast cancer: the long road},
journal = {Annals of Breast Surgery},
volume = {3},
number = {0},
year = {2019},
keywords = {},
abstract = {The risk of recurrence with early estrogen receptor positive breast cancer continues for decades (1). Because of that risk, long-term follow-up (LTFU) from trials of adjuvant endocrine therapy is quite important. The recent report of the BIG 1-98 trial from Ruhstaller and colleagues (2) provides us with another opportunity to view breast cancer through a longer time course.},
issn = {2616-2776}, url = {https://abs.amegroups.org/article/view/5070}
}